Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.
Saved in:
| Title: | Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation. |
|---|---|
| Authors: | McCurdy SR; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia. Electronic address: shannon.mccurdy@pennmedicine.upenn.edu., Solomon SR; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta., Shaffer BC; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., He M; CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis., Bolon YT; CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis., Blouin AG; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., Keyzner A; Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York., Socola FA; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane School of Medicine, New Orleans., Ibrahim U; Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York., Zou J; Department of Laboratory Medicine, Division of Pathology/Lab Medicine, MD Anderson Cancer Center, Houston., Safah H; Department of Medicine, LSU School of Medicine, New Orleans., Saba N; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane School of Medicine, New Orleans., Gadalla S; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., Paczesny S; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston., Marsh SGE; Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London, United Kingdom., Petersdorf EW; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington., Wang T; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI., Fuchs EJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2026 Jan; Vol. 32 (1), pp. 74.e1-74.e14. Date of Electronic Publication: 2025 Oct 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
